Manuel Castellón Leal

Private Equity Investor at Cross Road Biotech Inversiones Biotecnológicas SGEIC SA

Consumer Services

Finance

Health Technology

Profile

Mr. Manuel Castellón Leal is a Founding Partner & Legal Advisor at Cross Road Biotech Inversiones Biotecnológicas SGEIC SA. Mr. Castellón Leal also served on the board at Traslational Cancer Drugs Pharma SL.
He received his undergraduate degree from Universidad Complutense de Madrid and a graduate degree from the Instituto de Empresa SL.

Manuel Castellón Leal active positions

Companies	Position	Start
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA Cross Road Biotech Inversiones Biotecnológicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas SGEIC SA (Cross Road Biotech Inversiones Biotecnologicas) is a venture capital firm founded in 2001 by Enrique Castellon Leal. The firm is headquartered in Madrid, Spain.	Private Equity Investor	2000-12-31

All active positions of Manuel Castellón Leal

Former positions of Manuel Castellón Leal

Companies	Position	End
Traslational Cancer Drugs Pharma SL Traslational Cancer Drugs Pharma SL BiotechnologyHealth Technology Traslational Cancer Drugs Pharma SL engages in the discovery and development of therapeutic solutions for the treatment of cancer. Its TCD-717 choline kinase alpha inhibitor is an intravenously-administered small molecule designed to target cancer cells. It also provides technology in-licensing and out-licensing services. The company was founded by Juan Carlos San Juan on July 29, 2005 and is headquartered in Valladolid, Spain.	Director/Board Member	-

See the detail of Manuel Castellón Leal's experience

Training of Manuel Castellón Leal

Universidad Complutense de Madrid	Undergraduate Degree
Instituto de Empresa SL	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Manuel Castellón Leal's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA Cross Road Biotech Inversiones Biotecnológicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas SGEIC SA (Cross Road Biotech Inversiones Biotecnologicas) is a venture capital firm founded in 2001 by Enrique Castellon Leal. The firm is headquartered in Madrid, Spain.	Finance
Traslational Cancer Drugs Pharma SL Traslational Cancer Drugs Pharma SL BiotechnologyHealth Technology Traslational Cancer Drugs Pharma SL engages in the discovery and development of therapeutic solutions for the treatment of cancer. Its TCD-717 choline kinase alpha inhibitor is an intravenously-administered small molecule designed to target cancer cells. It also provides technology in-licensing and out-licensing services. The company was founded by Juan Carlos San Juan on July 29, 2005 and is headquartered in Valladolid, Spain.	Health Technology